IMPACT OF PATENT DUCTUS ARTERIOSUS CLOSURE ON LINEAR GROWTH AND WEIGHT GAIN IN CHILDREN: A PROSPECTIVE COHORT STUDY

Authors

  • Sri Lilijanti Widjaja
  • Pritania Prameswara Putri UNS
  • Bagus Artiko Cardiology Division, Department of Child Health, Faculty of Medicine Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta
  • Masayu Lubna Anniazi Cardiology Division, Department of Child Health, Faculty of Medicine Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta
  • Mylco Trisaputra Ahmadwirawan Cardiology Division, Department of Child Health, Faculty of Medicine Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

DOI:

https://doi.org/10.26911/theijmed.2026.11.2.944

Abstract

Background: Patent ductus arteriosus (PDA) can cause pulmonary circulatory volume overload and hemodynamic disturbances that result in feeding difficulties, recurrent infections, and growth retardation. PDA closure intervention is expected to improve physiological conditions, thereby supporting improvements in linear growth and weight gain.

Subject and Methods: This prospective cohort study was conducted at Dr. Moewardi General Hospital from January 2024 to July 2025. The target population was children diagnosed with patent ductus arteriosus (PDA). Subject was all of pediatric PDA patients at Dr. Moewardi General Hospital Surakarta who underwent PDA closure procedures (total sampling). Subjects with complete anthropometric data such as body weight and height at PDA pre-procedure, with 3 and 6 months after PDA procedure (post-procedure) were selected. The dependent variables were changes in height (cm) and body weight (kg), measured using standard anthropometric methods. Data were analyzed using the Friedman test for repeated measures, followed by paired Wilcoxon tests with Bonferroni correction for post-hoc comparisons.

Results: Total there were 48 children who underwent PDA closure with complete anthropometric data at PDA pre- and 3 to 6 months post-procedure. Mean height significantly increased 4.5% from 83,60 ± 26,23 cm at PDA pre-procedure to 87,34 ± 24,87 cm at 3 months post-procedure, and increased 8.1% to90,39 ± 23,64 cm at 6 months post-procedure( p<0,001). Mean body weight also significantly increased 9.3% from 11,49 ± 12,21 kg at PDA pre-procedure to 12,56 ± 11,93 kg at 3 months post-pocedure then increase 16.1% to 13,34 ± 11,88 kg at 6 months post-procedure (p<0,001). The height and weight of children with PDA closure increased over the observation period.

Conclusion: PDA closure is associated with a significant increase in linear growth and weight gain up to 6 months post-procedure.

Keywords:

Patent ductus arteriosus, PDA closure, linear growth, body weight, prospective cohort, Patent ductus arteriosus; PDA closure; linear growth; body weight; prospective cohort

Published

2026-04-10

Downloads

Issue

Section

Articles

Author Biography

Sri Lilijanti Widjaja

Cardiology Division, Department of Child Health, Faculty of Medicine Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

References

Babla K, Dassios T, Pushparajah K, Hickey A, Greenough A (2021). Premature infants with patent ductus arteriosus: postnatal growth according to type of management. Pediatr Neonatol. 62(1): 36–40. 10.1016/j.pedneo.-2020.¬08.0¬0¬5

Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, et al. (2022). Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 11(7): e025778. 10.1161/JAHA.122.025778

Baksh AK, Waworuntu DS, Umboh A (2024). Profil penyakit jantung bawaan di Bagian Ilmu Kesehatan Anak RSUP Prof. Dr. R. D. Kandou Manado periode September 2022–Agustus 2023. e-CliniC. 12(3): 330–334. 10.35790/ecl.v12i3.55352

Deselina B, Putra ST, Suradi R (2004). Prevalence of patent ductus arteriosus in premature infants at the neonatal ward, Cipto Mangunkusumo Hospital, Jakarta. Paediatr Indones. 44(11–12): 223–227

Gillam-Krakauer M, Mahajan K (2023). Patent ductus arteriosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing

Hartaty D, Noormanto N, Haksari EL (2016). Pertambahan berat badan pasca penutupan patent duktus arteriosus secara transkateter. Sari Pediatri. 17(3): 180–184. 10.14238/-sp17.3.2015.180-4

Hassan FM, Khatab AA, El-Zayat RS, Habib MS (2020). Study of serum leptin level in children with cyanotic and acyanotic congenital heart disease. Menoufia Med J. 33(1): 152–156. 10.4103/mmj.mmj_21_17

Herridge J, Tedesco-Bruce A, Gray S, Floh AA (2021). Feeding the child with congenital heart disease: a narrative review. Pediatr Med. 4: 5. 10.21037/-pm-20-77

Hsu HW, Lin TY, Liu YC, Yeh JL, Hsu JH (2021). Molecular mechanisms under¬lying remodeling of ductus arteriosus: looking beyond the prosta¬glandin pathway. Int J Mol Sci. 22(6): 3238. 10.3390/ijms22063238

Irfan M, Ali M, Lumban Tobing TC, Dalimunthe W, Adriansyah R (2021). Time period after transcatheter PDA closure with changes in left ventri-cular function and nutritional status. Paediatr Indones. 61(2): 100–106. 10.14238/pi61.2.2021.100-6

Kikuchi N, Goto T, Katsumata N, Murakami Y, Shinohara T, Maebayashi Y, Sakakibara A, Saito C, Hasebe Y, Hoshiai M, Nemoto A, Naito A (2024). Correlation between the closure time of patent ductus arteriosus in preterm infants and long-term neuro¬develop¬mental outcome. J Cardiovasc Dev Dis. 11(1): 26. 10.3390/jcdd11010026

Lee J, Marshall T, Buck H, Pamela M, Daack-Hirsch S (2025). Growth fail-ure in children with congenital heart disease. Children (Basel). 12(5): 616. 10.3390/children12050616

Leo H, Kuswiyanto RB, Rahayuningsih SE, Hafsah T (2019). Weight gain after transcatheter patent ductus arteriosus closure. Asia Pac J Pediatr Child Health. 3: 45

Mullaly R, Roth D, Smith A, Franklin O, McCallion N, El-Khuffash A (2025). Anthropometric measurements of infants in a risk-based patent ductus arteriosus treatment program. Early Hum Dev. 198: 106302. 10.1016/-j.earl¬humdev.2025.106302

Okadharma IGAMD, Yantie NPVK, Gunawijaya E (2022). Factors contributing to successful patent ductus arteriosus closure with first pharmacological course. Paediatr Indones. 62(2): 86–90. 10.14238/-pi62.2.2022.86-90

Salvatori G, Foligno S, Giovannini M (2022). Growth and nutrition in children with congenital heart disease. J Clin Med. 11(3): 668. 10.33-90/jcm11030668

Shulman A, Gordon A, Judin J, Foster C, Kazi A, Masemola M, Naidoo Y (2023). Associations and prevalence of patent ductus arteriosus amongst neonates in an academic hospital, 2013–2020: a retrospective study. Arch Dis Child. 108(Suppl 2): A144. 10.1136/archdischild-2023-rcpch.236

Suwitri NPE, Yantie NPVK, Gunawijaya E (2020). Short-term follow-up after percutaneous patent ductus arteriosus occlusion between low and high weight pediatric patients: a single center experience. Med J Indones. 29(3): 269–274. 10.13181/mji.¬oa.¬204154

Taşcı O, Özdemir R, Karademir S, Çelebi A, Karagöz T, Aykan HH, et al. (2023). The effect of percutaneous closure of ventricular septal defect on ghrelin and leptin levels. Erciyes Med J. 45(2): 156–161. 10.14744/etd.2022.-41848

Watanabe Y, Itabashi K, Taki M, Miyazawa T, Nakano Y, Murase M (2018). Body length and occipitofrontal circum-ference may be good indicators of neurodevelopment in very low birthweight infants: secondary publi-cation. Acta Paediatr. 107(6): 975–980. 10.1111/apa.14250